section name header

Basics ⬇

DESCRIPTION

Pregnancy Considerations

Not a contraindication to pregnancy. However, arrhythmias are sometimes exacerbated by pregnancy, especially if electrolyte disturbances develop.

EPIDEMIOLOGY

Prevalence depends on population studied, especially on what drugs are used in the population. All age groups can be affected, although presentation of the congenital form occurs more often in the younger age group and presentation of the acquired form in older patients after drug administration.

RISK FACTORS

ETIOLOGY

OTHER

COMMONLY ASSOCIATED CONDITIONS

None are known in the congenital form. For the acquired form, patients are usually treated with a QT-prolonging drug for a specific medical problem.

Diagnosis ⬆ ⬇

Signs and symptoms:

DIAGNOSTIC TESTS & INTERPRETATION

Lab

None for general use, although genetic screening is done in a research context

DIFFERENTIAL DIAGNOSIS

Medication (Drugs) ⬆ ⬇

Treatment ⬆ ⬇

ADDITIONAL TREATMENT

General Measures

SURGERY

see topic on Long QT syndrome for congenital variety.

IN-PATIENT CONSIDERATIONS

Admission Criteria

Ongoing Care ⬆ ⬇

FOLLOW-UP RECOMMENDATIONS

Patient Monitoring

PATIENT EDUCATION

PROGNOSIS

In the acquired form, outcome is generally good if precipitating causes are avoided. see topic on Long QT syndrome regarding congenital form.

Miscellaneous ⬆ ⬇

CODES

ICD9

427.1Paroxysmal ventricular tachycardia

SNOMED

Reference(s) ⬆ ⬇

ADDITIONAL READING

Author(s) ⬆

Peter Ott

Andrew E. Epstein